Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy.

Cancer Immunol Immunother · 2026 · PMC13013747 · PMID 41874671

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

did not reach statistical significancep = 0.101not close (p > 0.1)

Although the difference did not reach statistical significance, the 2-year OS was numerically greater in the ASCT group than in the CAR-T group [91.7% (95% CI: 53.9–98.8) vs. 74.1% (95% CI: 28.9–93.0); p = 0.101] (Fig. 4 A and B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.